Publications by authors named "Jacob Jochum"
Article Synopsis
- A study was done to see if we could use a special system to gather important cancer data easily using a tool called SmartPhrase.
- Before the new tool was used, only 32% of the necessary data was captured, but after using it for six months, that number jumped to 64% for stage and 81%-82% for other important information.
- The study found that this new way of gathering data didn't take more time for doctors and even helped them make better decisions for treating patients.
Background: Bevacizumab-induced gastrointestinal perforation is a rare but potentially devastating adverse event that has generated limited data on overall survival. Yet, such survival data are critical in guiding management.
Methods: This multi-site, single-institution retrospective study focused on all cancer patients who had received bevacizumab and who had suffered a well-documented gastrointestinal perforation from January 1, 2004 through January 20, 2022.
Background: Nanoliposomal irinotecan (Nal-IRI) is a preferred second-line treatment for metastatic pancreas cancer. It is unclear, however, whether patients who had received irinotecan derive benefit.
Methods: Medical records of metastatic pancreas cancer patients who had received irinotecan and then Nal-IRI were reviewed.
Purpose: Falls can occur in older cancer patients, but few studies have examined falls in an age-unspecified group of patients with locally advanced esophageal cancer. Because these patients are often administered neuropathy-inducing agents, are weak, and can develop orthostatic symptoms, examining falls appears relevant.
Methods: Electronic medical records were used to examine falls and their circumstances in locally advanced esophageal cancer patients treated with chemotherapy and radiation and often surgery.